• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

BORIS 对潜在致癌基因 SBSN 的剂量依赖性激活。

Dose-dependent activation of putative oncogene SBSN by BORIS.

机构信息

Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins Medical Institutions, Baltimore, Maryland, United States of America.

出版信息

PLoS One. 2012;7(7):e40389. doi: 10.1371/journal.pone.0040389. Epub 2012 Jul 5.

DOI:10.1371/journal.pone.0040389
PMID:22792300
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3390376/
Abstract

Testis-specific transcription factor BORIS (Brother of the Regulator of Imprinted Sites), a paralog and proposed functional antagonist of the widely expressed CTCF, is abnormally expressed in multiple tumor types and has been implicated in the epigenetic activation of cancer-testis antigens (CTAs). We have reported previously that suprabasin (SBSN), whose expression is restricted to the epidermis, is epigenetically derepressed in lung cancer. In this work, we establish that SBSN is a novel non-CTA target of BORIS epigenetic regulation. With the use of a doxycycline-inducible BORIS expressing vector, we demonstrate that relative BORIS dosage is critical for SBSN activation. At lower concentrations, BORIS induces demethylation of the SBSN CpG island and disruption and activation of chromatin around the SBSN transcription start site (TSS), resulting in a 35-fold increase in SBSN expression in the H358 human lung cancer cell line. Interestingly, increasing BORIS concentrations leads to a subsequent reduction in SBSN expression via chromatin repression. In a similar manner, increase in BORIS concentrations leads to eventual decrease of cell growth and colony formation. This is the first report demonstrating that different amount of BORIS defines its varied effects on the expression of a target gene via chromatin structure reorganization.

摘要

睾丸特异性转录因子 BORIS(印迹位点调节因子的兄弟)是一种与广泛表达的 CTCF 具有同源性的蛋白,被认为是其功能拮抗物,其在多种肿瘤类型中异常表达,并与癌症睾丸抗原(CTAs)的表观遗传激活有关。我们之前曾报道过,超basin(SBSN)的表达局限于表皮,在肺癌中其表观遗传被去抑制。在这项工作中,我们确定 SBSN 是 BORIS 表观遗传调控的一个新的非 CTA 靶标。通过使用可诱导表达 BORIS 的四环素诱导载体,我们证明了相对 BORIS 剂量对 SBSN 的激活至关重要。在较低浓度下,BORIS 诱导 SBSN CpG 岛去甲基化,并破坏和激活 SBSN 转录起始位点(TSS)周围的染色质,导致 H358 人肺癌细胞系中 SBSN 表达增加 35 倍。有趣的是,增加 BORIS 浓度会导致 SBSN 表达的后续减少,这是通过染色质抑制实现的。以类似的方式,增加 BORIS 浓度会导致细胞生长和集落形成的最终减少。这是第一个报道,证明不同量的 BORIS 通过染色质结构重排定义了其对靶基因表达的不同影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/158c/3390376/108e4603de06/pone.0040389.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/158c/3390376/a46545d3c016/pone.0040389.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/158c/3390376/6d1529274364/pone.0040389.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/158c/3390376/1b5825b3fd84/pone.0040389.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/158c/3390376/c747050609f8/pone.0040389.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/158c/3390376/9058159d94a3/pone.0040389.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/158c/3390376/108e4603de06/pone.0040389.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/158c/3390376/a46545d3c016/pone.0040389.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/158c/3390376/6d1529274364/pone.0040389.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/158c/3390376/1b5825b3fd84/pone.0040389.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/158c/3390376/c747050609f8/pone.0040389.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/158c/3390376/9058159d94a3/pone.0040389.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/158c/3390376/108e4603de06/pone.0040389.g006.jpg

相似文献

1
Dose-dependent activation of putative oncogene SBSN by BORIS.BORIS 对潜在致癌基因 SBSN 的剂量依赖性激活。
PLoS One. 2012;7(7):e40389. doi: 10.1371/journal.pone.0040389. Epub 2012 Jul 5.
2
Reciprocal binding of CTCF and BORIS to the NY-ESO-1 promoter coincides with derepression of this cancer-testis gene in lung cancer cells.CTCF和BORIS与NY-ESO-1启动子的相互结合与肺癌细胞中该癌胚基因的去抑制同时发生。
Cancer Res. 2005 Sep 1;65(17):7763-74. doi: 10.1158/0008-5472.CAN-05-0823.
3
Conditional expression of the CTCF-paralogous transcriptional factor BORIS in normal cells results in demethylation and derepression of MAGE-A1 and reactivation of other cancer-testis genes.正常细胞中CTCF旁系同源转录因子BORIS的条件性表达导致MAGE-A1去甲基化和去抑制,并使其他癌胚基因重新激活。
Cancer Res. 2005 Sep 1;65(17):7751-62. doi: 10.1158/0008-5472.CAN-05-0858.
4
BORIS binding to the promoters of cancer testis antigens, MAGEA2, MAGEA3, and MAGEA4, is associated with their transcriptional activation in lung cancer.BORIS 与癌症睾丸抗原 MAGEA2、MAGEA3 和 MAGEA4 的启动子结合,与它们在肺癌中的转录激活有关。
Clin Cancer Res. 2011 Jul 1;17(13):4267-76. doi: 10.1158/1078-0432.CCR-11-0653. Epub 2011 May 10.
5
DNA methylation-dependent regulation of BORIS/CTCFL expression in ovarian cancer.DNA甲基化依赖性调控卵巢癌中BORIS/CTCFL的表达
Cancer Immun. 2007 Dec 21;7:21.
6
CTCFL/BORIS is a methylation-independent DNA-binding protein that preferentially binds to the paternal H19 differentially methylated region.CTCFL/BORIS是一种不依赖甲基化的DNA结合蛋白,它优先结合父本H19差异甲基化区域。
Cancer Res. 2008 Jul 15;68(14):5546-51. doi: 10.1158/0008-5472.CAN-08-1005.
7
Hypomethylation of the CTCFL/BORIS promoter and aberrant expression during endometrial cancer progression suggests a role as an Epi-driver gene.CTCFL/BORIS启动子的低甲基化及在子宫内膜癌进展过程中的异常表达表明其作为一种表观遗传驱动基因发挥作用。
Oncotarget. 2014 Feb 28;5(4):1052-61. doi: 10.18632/oncotarget.1697.
8
Suprabasin is hypomethylated and associated with metastasis in salivary adenoid cystic carcinoma.Suprabasin 呈低甲基化状态,与唾液腺腺样囊性癌的转移相关。
PLoS One. 2012;7(11):e48582. doi: 10.1371/journal.pone.0048582. Epub 2012 Nov 7.
9
Expression of the CTCF-paralogous cancer-testis gene, brother of the regulator of imprinted sites (BORIS), is regulated by three alternative promoters modulated by CpG methylation and by CTCF and p53 transcription factors.CTCF旁系同源的癌胚基因,印记位点调节因子的兄弟(BORIS)的表达受三个可变启动子调控,这些启动子受CpG甲基化以及CTCF和p53转录因子的调节。
Nucleic Acids Res. 2007;35(21):7372-88. doi: 10.1093/nar/gkm896. Epub 2007 Oct 25.
10
Coordinated activation of candidate proto-oncogenes and cancer testes antigens via promoter demethylation in head and neck cancer and lung cancer.通过启动子去甲基化在头颈癌和肺癌中协调激活候选原癌基因和癌睾丸抗原。
PLoS One. 2009;4(3):e4961. doi: 10.1371/journal.pone.0004961. Epub 2009 Mar 23.

引用本文的文献

1
BORIS/CTCFL epigenetically reprograms clustered CTCF binding sites into alternative transcriptional start sites.BORIS/CTCFL 通过表观遗传重编程将聚集的 CTCF 结合位点转化为替代的转录起始位点。
Genome Biol. 2024 Jan 31;25(1):40. doi: 10.1186/s13059-024-03175-0.
2
CTCF and Its Multi-Partner Network for Chromatin Regulation.CTCF 及其多伙伴网络在染色质调控中的作用。
Cells. 2023 May 10;12(10):1357. doi: 10.3390/cells12101357.
3
Association of mutation and expression of the brother of the regulator of imprinted sites (BORIS) gene with breast cancer progression.

本文引用的文献

1
Transcription factor BORIS (Brother of the Regulator of Imprinted Sites) directly induces expression of a cancer-testis antigen, TSP50, through regulated binding of BORIS to the promoter.转录因子 BORIS(印记位点调节因子的兄弟)通过 BORIS 与启动子的调节结合直接诱导癌症睾丸抗原 TSP50 的表达。
J Biol Chem. 2011 Aug 5;286(31):27378-88. doi: 10.1074/jbc.M111.243576. Epub 2011 Jun 9.
2
Cancer-testis antigen, BORIS based vaccine delivered by dendritic cells is extremely effective against a very aggressive and highly metastatic mouse mammary carcinoma.基于癌症睾丸抗原 BORIS 的树突状细胞疫苗对一种非常侵袭性和高转移性的小鼠乳腺癌具有极强的疗效。
Cell Immunol. 2011;270(2):188-97. doi: 10.1016/j.cellimm.2011.05.007. Epub 2011 May 12.
3
兄弟调节印记基因(BORIS)基因突变和表达与乳腺癌进展的关系。
Oncotarget. 2023 May 26;14:528-541. doi: 10.18632/oncotarget.28442.
4
Three-dimensional genome landscape comprehensively reveals patterns of spatial gene regulation in papillary and anaplastic thyroid cancers: a study using representative cell lines for each cancer type.三维基因组景观全面揭示了甲状腺乳头状癌和间变性甲状腺癌中空间基因调控的模式:使用每种癌症类型的代表性细胞系进行的研究。
Cell Mol Biol Lett. 2023 Jan 6;28(1):1. doi: 10.1186/s11658-022-00409-6.
5
Suprabasin: Role in human cancers and other diseases.Suprabasin:在人类癌症和其他疾病中的作用。
Mol Biol Rep. 2022 Feb;49(2):1453-1461. doi: 10.1007/s11033-021-06897-7. Epub 2021 Nov 13.
6
Epigenetics in kidney diseases.肾脏疾病中的表观遗传学。
Adv Clin Chem. 2021;104:233-297. doi: 10.1016/bs.acc.2020.09.005. Epub 2020 Oct 21.
7
Suprabasin-A Review.Suprabasin-A 述评。
Genes (Basel). 2021 Jan 18;12(1):108. doi: 10.3390/genes12010108.
8
Aberrantly elevated suprabasin in the bone marrow as a candidate biomarker of advanced disease state in myelodysplastic syndromes.骨髓中异常升高的 suprabasin 作为骨髓增生异常综合征中晚期疾病状态的候选生物标志物。
Mol Oncol. 2020 Oct;14(10):2403-2419. doi: 10.1002/1878-0261.12768. Epub 2020 Aug 11.
9
BORIS/CTCFL promotes a switch from a proliferative towards an invasive phenotype in melanoma cells.BORIS/CTCFL促使黑色素瘤细胞从增殖表型向侵袭表型转变。
Cell Death Discov. 2020 Jan 2;6:1. doi: 10.1038/s41420-019-0235-x. eCollection 2020.
10
Atractyloside mimics knockdown to induce DNA damage in colorectal cancer cells.苍术苷模拟基因敲低以诱导结肠癌细胞中的DNA损伤。
Int J Clin Exp Pathol. 2018 Jul 1;11(7):3286-3293. eCollection 2018.
Secretome signature of invasive glioblastoma multiforme.侵袭性多形性胶质母细胞瘤的外泌体特征。
J Proteome Res. 2011 Jul 1;10(7):3149-59. doi: 10.1021/pr200210w. Epub 2011 May 31.
4
BORIS binding to the promoters of cancer testis antigens, MAGEA2, MAGEA3, and MAGEA4, is associated with their transcriptional activation in lung cancer.BORIS 与癌症睾丸抗原 MAGEA2、MAGEA3 和 MAGEA4 的启动子结合,与它们在肺癌中的转录激活有关。
Clin Cancer Res. 2011 Jul 1;17(13):4267-76. doi: 10.1158/1078-0432.CCR-11-0653. Epub 2011 May 10.
5
The tumor suppressor role of CTCF.CTCF 的肿瘤抑制作用。
J Cell Physiol. 2012 Feb;227(2):479-92. doi: 10.1002/jcp.22780.
6
CTCF and BORIS regulate Rb2/p130 gene transcription: a novel mechanism and a new paradigm for understanding the biology of lung cancer.CTCF 和 BORIS 调节 Rb2/p130 基因转录:一种新的机制和理解肺癌生物学的新范例。
Mol Cancer Res. 2011 Feb;9(2):225-33. doi: 10.1158/1541-7786.MCR-10-0493.
7
The structural complexity of the human BORIS gene in gametogenesis and cancer.人类 BORIS 基因在配子发生和癌症中的结构复杂性。
PLoS One. 2010 Nov 8;5(11):e13872. doi: 10.1371/journal.pone.0013872.
8
BORIS/CTCFL-mediated transcriptional regulation of the hTERT telomerase gene in testicular and ovarian tumor cells.BORIS/CTCFL 介导的端粒酶基因 hTERT 在睾丸和卵巢肿瘤细胞中的转录调控。
Nucleic Acids Res. 2011 Feb;39(3):862-73. doi: 10.1093/nar/gkq827. Epub 2010 Sep 28.
9
Pattern and clinical significance of cancer-testis gene expression in head and neck squamous cell carcinoma.头颈部鳞状细胞癌中癌-睾丸基因表达的模式和临床意义。
Int J Cancer. 2011 Jun 1;128(11):2625-34. doi: 10.1002/ijc.25607. Epub 2010 Oct 8.
10
BORIS/CTCFL expression is insufficient for cancer-germline antigen gene expression and DNA hypomethylation in ovarian cell lines.在卵巢细胞系中,BORIS/CTCFL的表达不足以促进癌胚抗原基因表达和DNA低甲基化。
Cancer Immun. 2010 Jul 23;10:6.